metformin has been researched along with Leukemia, Lymphoid in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vakana, E | 1 |
Altman, JK | 1 |
Glaser, H | 1 |
Donato, NJ | 1 |
Platanias, LC | 1 |
Levy, JM | 1 |
Stoll, C | 1 |
Amar, U | 1 |
Thierry, R | 1 |
Segura, N | 1 |
Bouaziz, M | 1 |
2 other studies available for metformin and Leukemia, Lymphoid
Article | Year |
---|---|
Antileukemic effects of AMPK activators on BCR-ABL-expressing cells.
Topics: Amino Acid Substitution; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Antineopl | 2011 |
[Exogenous steroid diabetes in a leukemic boy. Study of insulin and GH blood levels].
Topics: Blood Glucose; Child; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucose Tolerance Test; | 1973 |